Posted on February 28, 2025 | Jose Ramon Conejo-Garcia,MD, PHD – Duke Cancer Institute Cancer immunotherapy has long been dominated by T cells and immune checkpoint inhibitors. However, a groundbreaking presentation by Jose Ramon Conejo-Garcia, MD, PhD, from Duke Cancer Institute, is shifting the spotlight to an overlooked player: humoral immunity. In a recent talk, … Continue reading Immunotherapy Revolution Unveiled: How TLS-Derived Antibodies Are Changing Cancer Treatment AACR Io 2025